← SynDRA
DONITRIPTAN
SynDRA canonical compound SYN0026692 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HTR1D |
|---|
| Mechanism of action | Serotonin receptor agonist |
|---|
All known targets
- HTR1B
- HTR1D
- HTR1A
- HTR1E
- HTR1F
- HTR2A
- HTR5A
- HTR6
- PTGDR2
Mechanisms of action (all sources)
- Serotonin receptor agonist
- HTR1B AGONIST
- Serotonin 1b (5-HT1b) receptor agonist
- HTR1D AGONIST
- Serotonin 1d (5-HT1d) receptor agonist
- PTGDR2 ANTAGONIST
- G protein-coupled receptor 44 antagonist
- HTR1A FULL AGONIST
- HTR1B FULL AGONIST
- HTR1D FULL AGONIST
- HTR1E FULL AGONIST
- HTR1F FULL AGONIST
Cross-references
Synonyms
- Donitriptan hydrochloride
- F-11356
- Donitriptan mesylate
- F-12640
- Migraine therapy, Pierre Fabre
- 5-HT1D agonist, Pierre Fabre
- donitriptanum
- F11356
- RefChem:135638
- DTXCID2091465
- F12640
- Donitriptan [INN]
- UNII-70968BVH2J
- GTPL39
- DONITRIPTAN [WHO-DD]
- orb1309750
- SCHEMBL1388876
- SCHEMBL29387266
- VGA91252
- MFCD09832566
- AKOS040733006
- NCGC00370895-01
- NCGC00370895-03
- MS-26890
- DB-331636
- HY-106157
- CS-0025002
- NS00125371
- G13578
- T11075
- L000746
- BRD-K31092604-003-03-5
- EP5
- F 11356
- دونيتريبتان
- دونیتریپتان
- F863354
- DTXCID7091464
Look up DONITRIPTAN in the interactive SynDRA portal →